ESC 365 - Efficacy and safety of dapagliflozin in non-diabetic patients with anterior wall ST-segment elevation acute myocardial infarction (STEMI) in early-hospital period

Open Access

Efficacy and safety of dapagliflozin in non-diabetic patients with anterior wall ST-segment elevation acute myocardial infarction (STEMI) in early-hospital period

Session: Poster session 2 - Assessing and managing cardiovascular risk in patients with acute cardiac syndromes and stroke

Topic: Pharmacotherapy

Speaker: Miss A. Tavaratsyan (Yerevan, AM)

Event: ESC Preventive Cardiology 2024

Congress Presentation

Add to my library

About the speaker

Miss Ani Tavaratsyan

Yerevan (Armenia)

0 follower

6 more presentations in this session

Discussants - Assessing and managing cardiovascular risk in patients with acute cardiac syndromes and stroke

Differences in left atrial functionality between individuals with ischemic stroke and healthy controls: a comparative analysis

Speaker: Doctor D. Maritsa (London, GB)

The role of intracoronary physiology measurements and acetylcholine provocation testing in patients with INOCA. First data from Latvia

Speaker: Doctor B. Vitola (Riga, LV)

Association between apelin-12 and N-terminal pro-brain natriuretic peptide depending no- reflow phenomenon in STEMI patients

Speaker: Doctor X. Krasniqi (Pristina, XK)

How much protected? Assessment of cardiovascular risk factors in patients with previous cardiovascular events admitted for acute coronary syndrome.

Speaker: Doctor R. Gregorio Antunes Coelho (Setubal, PT)

Access the full session

Poster session 2 - Assessing and managing cardiovascular risk in patients with acute cardiac syndromes and stroke

Speakers: Miss A. Tavaratsyan, Doctor D. Maritsa, Doctor B. Vitola, Doctor X. Krasniqi, Doctor R. Gregorio Antunes Coelho

About the event

ESC Preventive Cardiology 2024

25 April - 27 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources